ES8501635A1 - Un procedimiento de fraccionamiento de plasma sanguineo - Google Patents

Un procedimiento de fraccionamiento de plasma sanguineo

Info

Publication number
ES8501635A1
ES8501635A1 ES531132A ES531132A ES8501635A1 ES 8501635 A1 ES8501635 A1 ES 8501635A1 ES 531132 A ES531132 A ES 531132A ES 531132 A ES531132 A ES 531132A ES 8501635 A1 ES8501635 A1 ES 8501635A1
Authority
ES
Spain
Prior art keywords
fractionation
plasma
blood plasma
exchanger
support particulates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531132A
Other languages
English (en)
Spanish (es)
Other versions
ES531132A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Recherches SA
Institut Merieux SA
Original Assignee
Rhone Poulenc Recherches SA
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Recherches SA, Institut Merieux SA filed Critical Rhone Poulenc Recherches SA
Publication of ES531132A0 publication Critical patent/ES531132A0/es
Publication of ES8501635A1 publication Critical patent/ES8501635A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/16—Organic material
    • B01J39/17—Organic material containing also inorganic materials, e.g. inert material coated with an ion-exchange resin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES531132A 1983-04-01 1984-03-30 Un procedimiento de fraccionamiento de plasma sanguineo Expired ES8501635A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8305441A FR2543448A1 (fr) 1983-04-01 1983-04-01 Procede de fractionnement du plasma

Publications (2)

Publication Number Publication Date
ES531132A0 ES531132A0 (es) 1984-12-01
ES8501635A1 true ES8501635A1 (es) 1984-12-01

Family

ID=9287485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531132A Expired ES8501635A1 (es) 1983-04-01 1984-03-30 Un procedimiento de fraccionamiento de plasma sanguineo

Country Status (16)

Country Link
US (1) US4675384A (enExample)
EP (1) EP0121468B1 (enExample)
JP (1) JPS6023320A (enExample)
AR (1) AR242115A1 (enExample)
AT (1) ATE32304T1 (enExample)
AU (1) AU565104B2 (enExample)
CA (1) CA1203478A (enExample)
DE (1) DE3469132D1 (enExample)
DK (1) DK164741C (enExample)
ES (1) ES8501635A1 (enExample)
FR (1) FR2543448A1 (enExample)
IE (1) IE57598B1 (enExample)
IN (1) IN160634B (enExample)
MX (1) MX7676E (enExample)
NO (1) NO166230C (enExample)
ZA (1) ZA842204B (enExample)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US4920152A (en) * 1986-05-13 1990-04-24 Purdue Research Foundation Reversed-phase packing material and method
US4911910A (en) * 1986-11-25 1990-03-27 Biotech Research Labs, Inc. Purified equine immunologlobulins and method of use thereof
US4806346A (en) * 1986-12-16 1989-02-21 American Home Products Corporation Method for isolation of antigen specific immunoglobulin
US4941974A (en) * 1987-06-17 1990-07-17 Dow Corning Corporation Method of making liquid chromatography dual zone packing materials
US4855054A (en) * 1987-06-17 1989-08-08 Dow Corning Corporation Using liquid chromatography dual zone packing materials
US4897197A (en) * 1987-06-17 1990-01-30 Dow Corning Corporation Using liquid chromatography packing materials
US4778600A (en) * 1987-06-17 1988-10-18 Dow Corning Corporation Liquid chromatography dual zone packing materials
US4773994A (en) * 1987-06-17 1988-09-27 Dow Corning Corporation Liquid chromatography packing materials
US4959340A (en) * 1987-06-17 1990-09-25 Dow Corning Corporation Method of making liquid chromatography packing materials
US4950634A (en) * 1988-02-11 1990-08-21 Dow Corning Corporation Method for producing dual zone materials by use of an organosilane mixture
US4950635A (en) * 1988-02-11 1990-08-21 Dow Corning Corporation Method for producing dual zone materials by catalyzed halosilylation
US5277818A (en) * 1988-10-31 1994-01-11 The Green Cross Corporation Albumin preparation and process for preparing the same
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
ATE269872T1 (de) * 1990-04-19 2004-07-15 Bayer Ag Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5186838A (en) * 1991-03-04 1993-02-16 Biotage Inc. Chromatographic packing material having functionalized polymeric coating on a substrate
CA2102425A1 (en) * 1991-03-04 1992-09-05 Ethan S. Simon Butadiene acrylonitrile polymeric coating and chromatographic packing material
US5167822A (en) * 1991-03-04 1992-12-01 Biotage Inc. Butadiene acrylonitrile polymeric coating for chromatographic packing material
DK0524681T3 (da) * 1991-07-12 2000-04-10 Dsm Nv Fremgangsmåde til oprensning af serumalbumin
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
ES2046122B1 (es) * 1992-06-04 1994-10-01 Grifols Grupo Sa Procedimiento para la obtencion de albumina serica humana purificada.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5512169A (en) * 1992-12-30 1996-04-30 Dow Corning Corporation Liquid column packing materials
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
US5486293A (en) * 1994-03-21 1996-01-23 Hemasure, Inc. Removal of small exogenous molecules from biological fluids
JP3702474B2 (ja) 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
US6114466A (en) * 1998-02-06 2000-09-05 Renal Tech International Llc Material for purification of physiological liquids of organism
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
AUPP971399A0 (en) * 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
US6833238B2 (en) * 2002-01-04 2004-12-21 Applera Corporation Petal-array support for use with microplates
US20040018559A1 (en) * 2002-07-26 2004-01-29 Applera Corporation Size-exclusion ion-exchange particles
US6861473B2 (en) * 2003-02-28 2005-03-01 Baxter International Inc. Macromolecular ketoaldehydes
US20050181378A1 (en) * 2004-02-18 2005-08-18 Applera Corporation Polyelectrolyte-coated size-exclusion ion-exchange particles
US20060160122A1 (en) * 2004-02-18 2006-07-20 Applera Corporation Polyelectrolyte-coated size-exclusion ion-exchange particles
US20050196856A1 (en) * 2004-02-18 2005-09-08 Applera Corporation Polyelectrolyte-coated size-exclusion ion-exchange particles
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
WO2008070680A1 (en) * 2006-12-04 2008-06-12 Berkeley Heartlab, Inc Separation of high density lipoproteins on polymer monoliths with decreased hydrophobicity
DE102007038413A1 (de) * 2007-08-09 2009-02-12 Beiersdorf Ag Kosmetische Emulgatorkombination
FR2952639B1 (fr) * 2009-11-16 2013-08-30 Lab Francais Du Fractionnement Procede de purification de facteur b
US20140031527A1 (en) * 2012-07-27 2014-01-30 Csl Limited Method for polishing albumin
US11718643B2 (en) 2012-11-13 2023-08-08 Cytiva Bioprocess R&D Ab Multimodal anion exchange matrices
EP2735360B1 (en) * 2012-11-26 2017-04-12 Gambro Lundia AB Adsorber device combining beads and hollow fiber membranes
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
ES2920381T3 (es) * 2014-08-15 2022-08-03 Merck Patent Gmbh Purificación de inmunoglobulinas a partir de plasma
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1009217A (en) * 1972-10-03 1977-04-26 Frederick Grosser Insoluble crosslinked homopolymers and copolymers, polymerized on an inert substrate
US3941718A (en) * 1972-10-03 1976-03-02 Gaf Corporation Insoluble crosslinked homopolymers and copolymers, polymerized on an inert substrate
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
LU73094A1 (enExample) * 1975-07-29 1977-03-24
FR2359634A2 (fr) * 1976-07-28 1978-02-24 Rhone Poulenc Ind Procede de separation de proteines par echange d'ions
FR2321932A1 (fr) * 1975-08-28 1977-03-25 Rhone Poulenc Ind Procede de separation de proteines par echange d'ions
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4229342A (en) * 1977-05-18 1980-10-21 Rhone-Poulenc Industries Process for extracting proteins from milk using silica and anion exchange resins
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
FR2403098A1 (fr) * 1977-09-19 1979-04-13 Merieux Inst Nouveau materiau capable de fixer de facon reversible des macromolecules biologiques, sa preparation et son application
US4176056A (en) * 1978-04-27 1979-11-27 Pennwalt Corporation Cyclic operation of a bed of mixed ion exchange resins
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
JPH115684A (ja) * 1997-06-13 1999-01-12 Nissei Eng:Kk チャック吊り上げ装置

Also Published As

Publication number Publication date
ZA842204B (en) 1984-10-31
IE840802L (en) 1984-10-01
IN160634B (enExample) 1987-07-18
ES531132A0 (es) 1984-12-01
FR2543448A1 (fr) 1984-10-05
JPS6023320A (ja) 1985-02-05
NO166230B (no) 1991-03-11
JPH0520439B2 (enExample) 1993-03-19
DE3469132D1 (en) 1988-03-10
NO166230C (no) 1991-06-19
ATE32304T1 (de) 1988-02-15
AU565104B2 (en) 1987-09-03
US4675384A (en) 1987-06-23
DK174484D0 (da) 1984-03-30
EP0121468A2 (fr) 1984-10-10
DK174484A (da) 1984-10-02
AU2626484A (en) 1984-10-04
MX7676E (es) 1990-08-02
DK164741C (da) 1992-12-28
EP0121468B1 (fr) 1988-02-03
IE57598B1 (en) 1993-01-27
CA1203478A (fr) 1986-04-22
AR242115A1 (es) 1993-03-31
EP0121468A3 (en) 1985-07-17
DK164741B (da) 1992-08-10
NO841266L (no) 1984-10-02

Similar Documents

Publication Publication Date Title
ES8501635A1 (es) Un procedimiento de fraccionamiento de plasma sanguineo
EP0119954A3 (en) 3-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
AU5024885A (en) A method for purifying a physiologically active substance produced by recombinant DNA technique
IL88118A (en) Ion-exchange chromatographic method of purifying proteins
NZ224295A (en) A method of producing native or physiologically active secondary structure in physiologically inactive proteins
EP0087686A3 (en) Homogeneous human immune interferon and process therefor
FR2502626B1 (fr) Acides oxazaphosphorin-4-thio-alcanesulfoniques, leurs sels neutres, procede pour leur preparation et preparations pharmaceutiques qui les contiennent
IE893155L (en) A method for separating glycolipids from a lipid mixture and¹uses of the fractions obtained
FR2575669B1 (fr) Procede pour la separation des isotopes d'uranium par chromatographie d'oxydoreduction
FR2381783A1 (fr) Procede de production de lysozyme humaine
GB8827069D0 (en) Column chromatograph & process for operation thereof
IT8449183A1 (it) Soluzione proteinica per somministrazione parenterale in malattie croniche da carenza di proteine
GB2126920B (en) Liquid active substance-containing membrane and process for its production
FR2547814B1 (fr) Derives de l'acide bicyclo (3.2.1.) octane carboxylique, leur procede de preparation et leur application therapeutique
FR2587621B1 (fr) Procede pour la fabrication de preparations pharmaceutiques de peptides presentant une capacite de resorption accrue
FR2543954B1 (fr) Acylamino-4 aza-1 adamantanes, procede pour leur preparation et application en therapeutique
GR3003950T3 (enExample)
EP0422585A3 (en) Novel product/process/application for improving carbon adsorptive capacity by oxygen addition in aqueous systems
ES285700U (es) Monopatin
FR2616782B1 (fr) Procede de separation d'acides amines
RO89750A2 (ro) Procedeu de preparare a comprimatelor de metotrexat
PL255010A1 (en) Column for preparative liquid chromatography,in particular for use in production processes
KR840001106U (ko) 이온교환식 강화유리제품 제조용 전극체
PL268364A1 (en) Ion exchange column